132 related articles for article (PubMed ID: 15126604)
1. Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Moshynska O; Sankaran K; Pahwa P; Saxena A
J Natl Cancer Inst; 2004 May; 96(9):673-82. PubMed ID: 15126604
[TBL] [Abstract][Full Text] [Related]
2. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Nenning UC; Eckert C; Wellmann S; Barth A; Henze G; Seeger K
J Natl Cancer Inst; 2005 Jul; 97(14):1091-2; author reply 1093-5. PubMed ID: 16030311
[No Abstract] [Full Text] [Related]
3. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Dicker F; Rauhut S; Kohlmann A; Kern W; Schoch C; Haferlach T; Schnittger S
J Natl Cancer Inst; 2005 Jul; 97(14):1092-3; author reply 1093-5. PubMed ID: 16030312
[No Abstract] [Full Text] [Related]
4. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Iglesias-Serret D; Coll-Mulet L; Santidrián AF; Navarro-Sabaté A; Domingo A; Pons G; Gil J
J Natl Cancer Inst; 2005 Jul; 97(14):1090-1; author reply 1093-5. PubMed ID: 16030310
[No Abstract] [Full Text] [Related]
5. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Vargas RL; Felgar RE; Rothberg PG
J Natl Cancer Inst; 2005 Jul; 97(14):1089-90; author reply 1093-5. PubMed ID: 16030309
[No Abstract] [Full Text] [Related]
6. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Freeman SN; Bepler G; Haura E; Sutphen R; Cress WD
J Natl Cancer Inst; 2005 Jul; 97(14):1088-9; author reply 1093-5. PubMed ID: 16030308
[No Abstract] [Full Text] [Related]
7. The relevance of sequence insertions in the Mcl-1 promoter in chronic lymphocytic leukemia and in normal cells.
Coenen S; Pickering B; Potter KN; Johnson PW; Stevenson FK; Packham G
Haematologica; 2005 Sep; 90(9):1285-6. PubMed ID: 16154859
[TBL] [Abstract][Full Text] [Related]
8. MCL-1 promoter insertions dial-up aggressiveness of chronic leukemia.
Kitada S; Reed JC
J Natl Cancer Inst; 2004 May; 96(9):642-3. PubMed ID: 15126592
[No Abstract] [Full Text] [Related]
9. Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia.
Johnston JB; Paul JT; Neufeld NJ; Haney N; Kropp DM; Hu X; Cheang M; Gibson SB
Leuk Lymphoma; 2004 Oct; 45(10):2017-27. PubMed ID: 15370246
[TBL] [Abstract][Full Text] [Related]
10. Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers.
Pepper C; Lin TT; Pratt G; Hewamana S; Brennan P; Hiller L; Hills R; Ward R; Starczynski J; Austen B; Hooper L; Stankovic T; Fegan C
Blood; 2008 Nov; 112(9):3807-17. PubMed ID: 18599795
[TBL] [Abstract][Full Text] [Related]
11. Strong correlation between VEGF and MCL-1 mRNA expression levels in B-cell chronic lymphocytic leukemia.
Véronèse L; Tournilhac O; Verrelle P; Davi F; Dighiero G; Chautard E; Veyrat-Masson R; Kwiatkowski F; Goumy C; Gouas L; Bay JO; Vago P; Tchirkov A
Leuk Res; 2009 Dec; 33(12):1623-6. PubMed ID: 19487028
[TBL] [Abstract][Full Text] [Related]
12. Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiated.
Starczynski J; Pepper C; Pratt G; Hooper L; Thomas A; Milligan D; Bentley P; Fegan C
J Clin Oncol; 2005 Mar; 23(7):1514-21. PubMed ID: 15735127
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Mcl-1 expression in context to bone marrow stromal microenvironment in chronic lymphocytic leukemia.
Balakrishnan K; Burger JA; Fu M; Doifode T; Wierda WG; Gandhi V
Neoplasia; 2014 Dec; 16(12):1036-46. PubMed ID: 25499217
[TBL] [Abstract][Full Text] [Related]
14. c-Abl regulates Mcl-1 gene expression in chronic lymphocytic leukemia cells.
Allen JC; Talab F; Zuzel M; Lin K; Slupsky JR
Blood; 2011 Feb; 117(8):2414-22. PubMed ID: 21220745
[TBL] [Abstract][Full Text] [Related]
15. Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia.
Nückel H; Frey UH; Bau M; Sellmann L; Stanelle J; Dürig J; Jöckel KH; Dührsen U; Siffert W
Blood; 2007 Jan; 109(1):290-7. PubMed ID: 16960146
[TBL] [Abstract][Full Text] [Related]
16. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
[TBL] [Abstract][Full Text] [Related]
17. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
[TBL] [Abstract][Full Text] [Related]
18. MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL.
Dong HJ; Fang C; Fan L; Zhu DX; Wang DM; Zhu HY; Zhuang Y; Miao KR; Liu P; Xu W; Li JY
Int J Cancer; 2012 May; 130(9):2054-61. PubMed ID: 21647873
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia.
Xu W; Li JY; Wu YJ; Yu H; Shen QD; Li L; Fan L; Qiu HX
Leuk Res; 2008 Jul; 32(7):1071-7. PubMed ID: 18035414
[TBL] [Abstract][Full Text] [Related]
20. Cyclin E but not bcl-2, bax or mcl-1 is differentially expressed in ZAP 70-positive and ZAP 70-negative B-CLL cells.
Bogner C; Sandherr M; Perker M; Weick K; Ringshausen I; Peschel C; Decker T
Ann Hematol; 2006 Jul; 85(7):458-62. PubMed ID: 16538501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
